{"eventGroups":[{"description":"Participants received 4 mg pomalidomide administered by mouth on Days 1-21 of each 28-day treatment cycle and 40 mg dexamethasone (participants \\> 75 years of age received 20 mg dexamethasone) administered by mouth once per day on Days 1, 8, 15, and 22 of a 28-day cycle until disease progression or pomalidomide discontinuation for any reason.","id":"EG000","otherNumAffected":36,"otherNumAtRisk":36,"seriousNumAffected":16,"seriousNumAtRisk":36,"title":"Pomalidomide Plus Dexamethasone"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":36}],"term":"NEUTROPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":36}],"term":"THROMBOCYTOPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":36}],"term":"ANAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":36}],"term":"LYMPHOPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":36}],"term":"LEUKOPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":36}],"term":"PYREXIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":36}],"term":"OEDEMA PERIPHERAL"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":36}],"term":"MALAISE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":36}],"term":"FATIGUE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":36}],"term":"CONSTIPATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":36}],"term":"DIARRHOEA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":36}],"term":"NAUSEA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"ABDOMINAL PAIN UPPER"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HAEMORRHOIDS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"PROCTALGIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"VOMITING"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":36}],"term":"RASH"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"RASH MACULO-PAPULAR"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"DECUBITUS ULCER"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":36}],"term":"NASOPHARYNGITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":36}],"term":"UPPER RESPIRATORY TRACT INFECTION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"BRONCHITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"PNEUMONIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":36}],"term":"DECREASED APPETITE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":36}],"term":"HYPERURICAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":36}],"term":"HYPOALBUMINAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HYPERCALCAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"HYPERGLYCAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HYPOCALCAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":36}],"term":"HYPOKALAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HYPONATRAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"HYPOPHOSPHATAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":36}],"term":"DYSGEUSIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HYPERSOMNIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"PERIPHERAL SENSORY NEUROPATHY"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"SOMNOLENCE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":36}],"term":"EPISTAXIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"HYPOXIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"DYSPHONIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"DYSPNOEA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"PLEURAL EFFUSION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HICCUPS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"ANXIETY"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"ALANINE AMINOTRANSFERASE INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"ASPARTATE AMINOTRANSFERASE INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"BLOOD ALKALINE PHOSPHATASE INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"MYALGIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"HEPATIC FUNCTION ABNORMAL"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"HERPES ZOSTER"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"CYSTITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"GASTROENTERITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"DIABETES MELLITUS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":36}],"term":"INSOMNIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"RESTLESSNESS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"INCREASED APPETITE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HEADACHE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"NEUROPATHY PERIPHERAL"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"TREMOR"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"MUSCLE SPASMS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"WEIGHT DECREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"WEIGHT INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HYPOTENSION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HYPOTHYROIDISM"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"HYPOGAMMAGLOBULINAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":36}],"term":"Pharyngitis"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":36}],"term":"ANAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"NEUTROPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"THROMBOCYTOPENIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":36}],"term":"PNEUMONIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"PNEUMONIA PNEUMOCOCCAL"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"ASTHMA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"CHRONIC OBSTRUCTIVE PULMONARY DISEASE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"HYPOXIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"PLEURAL EFFUSION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"MULTI-ORGAN FAILURE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"PYREXIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"DECREASED APPETITE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"HYPONATRAEMIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"CANCER PAIN"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":36}],"term":"CONSTIPATION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"HEPATIC FUNCTION ABNORMAL"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"SPINAL COMPRESSION FRACTURE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"BLOOD FIBRINOGEN DECREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"BACK PAIN"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"URINARY RETENTION"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"SHOCK HAEMORRHAGIC"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"BRONCHITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"MENINGITIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"PNEUMOCYSTIS JIROVECII PNEUMONIA"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"SEPSIS"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"INTERSTITIAL LUNG DISEASE"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"C-REACTIVE PROTEIN INCREASED"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (16.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":36}],"term":"CARDIAC FAILURE"}],"timeFrame":"From the start of study drug through 28 days after the last dose of study drug. Maximum duration of study treatment was 80.9 weeks; up to 25 September 2015 data cut-off"}